Business
MedMira Announces Correction to Settlement of Debt
HALIFAX, March 28 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a global m...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\nHALIFAX, March 28 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions,\nannounces a correction to the February 20, 2008 press release in regard to the\nSettlement of Debt. The company will issue 5,681,818 common shares at a price\nof $0.264 per share subject to the approval of the TSX Venture Exchange.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\ndiagnostics. The company's tests provide hospitals, labs, clinics and\nindividuals around the world with reliable, rapid diagnosis for diseases such\nas HIV and hepatitis C in just three minutes. The company's tests are sold\nunder the Reveal(R), MiraWell(R), MiraCare(TM) and Multiplo(TM) brands in\nglobal markets. MedMira's rapid HIV test is the only one in the world to\nachieve regulatory approvals in Canada, the United States, China and the\nEuropean Union.\n\n\nIn January 2006, MedMira launched the Maple Biosciences division to\ndevelop and commercialize diagnostic instruments based on two revolutionary\nbiosensor-based technology platforms. The solutions developed by Maple\nBiosciences will enable routine laboratory tests to be performed in a matter\nof minutes, increasing laboratory automation, streamlining the diagnosis of\nmultiple conditions and diseases and positioning MedMira to be a leading\nparticipant in the emerging fields of personalized medicine and molecular\ndiagnostics. For more information visit www.maplebio.com.\n\n\nMedMira's corporate offices and manufacturing facilities are located in\nHalifax, Nova Scotia, Canada with a representative office in China. Maples\nBiosciences' labs are located in Toronto, Ontario. For more information visit\nMedMira's website at www.medmira.com.\n\n\nThis news release contains forward-looking statements, which involve risk\nand uncertainties and reflect the company's current expectation regarding\nfuture events. Actual events could materially differ from those projected\nherein and depend on a number of factors including, but not limited to,\nchanging market conditions, successful and timely completion of clinical\nstudies, uncertainties related to the regulatory approval process,\nestablishment of corporate alliances and other risks detailed from time to\ntime in the company quarterly fi...